Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) EPS (Basic) (2020 - 2025)

Celularity (CELU) has disclosed EPS (Basic) for 6 consecutive years, with -$0.88 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) fell 20.55% to -$0.88 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.32, a 172.13% decrease, with the full-year FY2024 number at -$2.64, up 76.04% from a year prior.
  • EPS (Basic) was -$0.88 for Q3 2025 at Celularity, up from -$1.02 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.08 in Q4 2022 to a low of -$4.12 in Q1 2023.
  • A 5-year average of -$0.84 and a median of -$0.58 in 2024 define the central range for EPS (Basic).
  • Biggest YoY gain for EPS (Basic) was 118.65% in 2021; the steepest drop was 8600.0% in 2021.
  • Celularity's EPS (Basic) stood at $0.51 in 2021, then soared by 111.76% to $1.08 in 2022, then fell by 22.22% to $0.84 in 2023, then tumbled by 169.05% to -$0.58 in 2024, then tumbled by 51.72% to -$0.88 in 2025.
  • Per Business Quant, the three most recent readings for CELU's EPS (Basic) are -$0.88 (Q3 2025), -$1.02 (Q2 2025), and -$0.84 (Q1 2025).